-
s Commentary on “Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer” by Shaker A. Mousa, Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, United States - Peptide-Conjugated Nanoparticles for Multimodal Nanomedicine
- Source: Current Medicinal Chemistry, Volume 27, Issue 17, May 2020, p. 2927 - 2928
-
- 01 May 2020
- Previous Article
- Table of Contents
- Next Article
There is no abstract available.
© Bentham Science Publishers